Therapeutic Cloning vs. Reproductive Cloning
Therapeutic cloning offers a potential mechanism for repairing defective, diseased, or degenerating tissues that avoids problems associated with tissue rejection. For many disorders, a traditional transplant is not an option. Scientist hope that therapeutic cloning can one day offer a cure for a wide range of diseases, such as cardiovascular disease, diabetes, autoimmune disease, cancer, osteoporosis, Alzheimer's disease, and Parkinson's disease, as well as severe burns, spinal cord injuries, and birth defects. Therapeutic cloning does not involve reproductive cloning because development is stopped at the blastocyst stage.
Recall that in reproductive cloning, somatic cell nuclear transfer (SCNT) is used to produce an embryo, which then is implanted into the uterus of a female. The pregnancy, if carried to term, will produce an identical copy (a "clone") of the somatic (adult) cell donor. However, unlike portrayals in science fiction movies, these "clones" would not contain the same personality or memories as the donor individual. While the clone would be genetically identical, he or she would be as similar or dissimilar as an identical twin would be. His or her personality and memories would be the product of the individual environment and experiences. All of the environmental insults (such as exposure to harmful UV sunlight or toxic chemicals) to the DNA of the somatic cell will be transferred to the clone.
Another significant consideration with reproductive cloning is the associated health risks to the cloned organism and the mother. Cloned animals, from sheep to cows, have experienced significant health effects, including premature and advanced aging and a wide range of other problems, which scientists do not fully understand. Approximately 98% of all cloning attempts fail.
In the US, laws are being considered to outlaw reproductive cloning, but not therapeutic cloning. Most scientists do not support reproductive cloning. For more information, visit http://stemcells.nih.gov/
- Guinan, P. (2002). Bioterrorism, embryonic stem cells, and Frankenstein. Journal of Religion and Health, 41(4), 305-309.
- Lanza, R. P., Caplan, A. L., Silber, L. M., Cibelli, J. B., West, M. D., & Green, R. M. (2000). The ethical validity of using nuclear Transfer in Human Transplantation. JAMA, 284(24), 3175-3179.
- Rhind, S. M., King, T. J., Harkness, L. M., Bellamy, C., Wallace, W., DeSousa, P., & Wilmut, I. (2003). Cloned lambs: Lessons from pathology. Nature Biotechnology, 21(7), 744-745.
- Rhind, S. M., Taylor, J. E., De Sousa, P. A., King, T. J., McGarry, M., & Wilmut, I. (2003). Human cloning: Can it be made safe? Nature Reviews: Genetics, 4, 855-864.
Your slide tray is being processed.
Funded by the following grant(s)
My Health My World: National Dissemination
Grant Number: 5R25ES009259
The Environment as a Context for Opportunities in Schools
Grant Number: 5R25ES010698, R25ES06932
Foundations for the Future: Capitalizing on Technology to Promote Equity, Access and Quality in Elementary Science Education